Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
A2 Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
University of Nebraska
Adela, Inc
Elephas
Kura Oncology, Inc.
Elephas
Palo Alto Veterans Institute for Research
Dana-Farber Cancer Institute
Massive Bio, Inc.
7 Hills Pharma, LLC
A2 Biotherapeutics Inc.
Western University, Canada
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Chinese University of Hong Kong
Molecure S.A.
Centre Georges Francois Leclerc
University Health Network, Toronto
Aurigene Discovery Technologies Limited
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Organisation for Research and Treatment of Cancer - EORTC
University of Sydney
N.N. Petrov National Medical Research Center of Oncology
IRCCS San Raffaele
Hospices Civils de Lyon